SCHEMBL589241

SCHEMBL589241

CC(C)(C)N(C(=O)O)C1CCc2cc(Br)ccc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.40
DRD3 P35462 9/20 0.39
MCHR1 Q99705 1/20 0.38
DRD2 P14416 8/20 0.37
DRD4 P21917 1/20 0.37
CYP2C8 P10632 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
KCNH2 Q12809 1/20 0.36
DRD1 P21728 1/20 0.36
ADRA2A P08913 1/20 0.35
PNMT P11086 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
HSD17B3 P37058 2/20 0.35
SRD5A1 P18405 1/20 0.35
SRD5A2 P31213 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1784095 0.89 PNMT (0.39) FAAHADRA2APNMTADRA2BADRA2C
SCHEMBL1026496 0.82 HTR1A (0.48) DRD3DRD2
SCHEMBL16868798 0.81 MCHR1 (0.41) DRD3MCHR1DRD2DRD4PNMT
SCHEMBL16868778 0.81 MCHR1 (0.41) DRD3MCHR1DRD2DRD4PNMT
SCHEMBL16868763 0.81 MCHR1 (0.41) DRD3MCHR1DRD2DRD4PNMT
SCHEMBL16868783 0.81 MCHR1 (0.41) DRD3MCHR1DRD2DRD4PNMT
SCHEMBL354165 0.80 DRD2 (0.61) DRD3DRD2DRD4CYP2C9CA1
SCHEMBL18497279 0.77 ACHE (0.40) DRD2SRD5A1SRD5A2ACHE
SCHEMBL1827400 0.77 SRD5A1 (0.40) SRD5A1SRD5A2ACHE
SCHEMBL23318402 0.77 MCHR1 (0.40) FAAHDRD3MCHR1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114601-A1 NEW ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-10 US disclosed
US-8114888-B2 Isothiazoloquinolones and related compounds as anti-infective agents ACHILLION PHARMACEUTICALS, INC. (US) 2012-02-14 US disclosed
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-15 US disclosed
EP-1848723-B1 NEW ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS INC (US) 2010-12-15 EP disclosed
US-20060235041-A1 New isothiazoloquinolones and related compounds as anti-infective agents ACHILLION PHARMACEUTICALS, INC. 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235041-A1 New isothiazoloquinolones and related compounds as anti-infective agents TOP1, RECQL, IRF3 FAAH 3842/4885DRD3 2034/4885MCHR1 4259/4885
US-20120114601-A1 NEW ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS TOP1, RECQL, IRF3 FAAH 3842/4885DRD3 2034/4885MCHR1 4259/4885
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS TOP1, IRF3, RECQL FAAH 3815/4885DRD3 2175/4885MCHR1 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.